- Home
- HBB vs NAUT Comparison
HBB vs NAUT Comparison
Compare HBB & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HBB | NAUT |
|---|---|---|
| Founded | 1904 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.9M | 245.0M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | HBB | NAUT |
|---|---|---|
| Price | $18.36 | $2.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.9K | ★ 217.3K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | ★ 24.53 | N/A |
| EPS | ★ 2.34 | N/A |
| Revenue | ★ $607,430,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.13 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.72 | $0.62 |
| 52 Week High | $21.20 | $2.54 |
Technical Indicators
Market Signals| Indicator | HBB | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 58.10 | 54.62 |
| Support Level | $18.45 | $1.75 |
| Resistance Level | $20.30 | $2.29 |
| Average True Range (ATR) | 1.04 | 0.15 |
| MACD | 0.17 | -0.01 |
| Stochastic Oscillator | 56.21 | 56.47 |
Price Performance
Historical ComparisonAbout HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.